{"id":474742,"date":"2020-03-18T12:30:02","date_gmt":"2020-03-18T12:30:02","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=474742"},"modified":"2020-03-18T12:30:02","modified_gmt":"2020-03-18T12:30:02","slug":"dry-eye-disease-ded-market-insights-epidemiology-and-market-forecast2028","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/dry-eye-disease-ded-market-insights-epidemiology-and-market-forecast2028_474742.html","title":{"rendered":"Dry Eye Disease (DED) Market Insights, Epidemiology and Market Forecast-2028"},"content":{"rendered":"<div style=\"float:right;  width:250px; padding:8px 10px 10px 10px;\"><a href=\"https:\/\/www.abnewswire.com\/uploads\/1584513499.jpeg\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"Dry Eye Disease (DED) Market Insights, Epidemiology and Market Forecast-2028\" src=\"https:\/\/www.abnewswire.com\/uploads\/1584513499.jpeg\" alt=\"Dry Eye Disease (DED) Market Insights, Epidemiology and Market Forecast-2028\" width=\"225\" height=\"225\" \/><\/a><\/div>\n<div style=\"font-style:italic; padding:8px 0px;\">DelveInsight&#8217;s &#8220;Dry Eye Disease (DED) Market Insights, Epidemiology and Market Forecast-2028&#8221; report delivers an in-depth understanding of the disease, historical and forecasted epidemiology as well as the market trends of DED in EU5 (Germany, Spain, Italy, France and United Kingdom).<\/p>\n<\/div>\n<p style=\"text-align: justify;\"><strong>Albany, NY &#8211;<\/strong> DelveInsight launched its new report on&nbsp;<a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/dry-eye-disease-market\" target=\"_blank\">Dry Eye Disease (DED) Market Insights, Epidemiology and Market Forecast-2028<\/a>.<\/p>\n<p style=\"text-align: justify;\">DelveInsight&#8217;s &#8220;<strong>Dry Eye Disease (DED) Market Insights, Epidemiology and Market Forecast-2028<\/strong>&#8221;&nbsp;report delivers an in-depth understanding of the disease, historical and forecasted epidemiology as well as the market trends of DED&nbsp;in EU5 (Germany, Spain, Italy, France and United Kingdom).<\/p>\n<p style=\"text-align: justify;\"><strong>Some key facts of the report:<\/strong><br \/>1. Dry eye is a very common condition in the UK, affecting one in four people in the UK.<br \/>2. 6.8% of the US adult population was projected to have diagnosed Dry Eye Disease i.e., &gt;16 million people.<br \/>3. Dry Eye Disease prevalence for clinically diagnosed cases were 10.1% in male subjects and 21.5% in female subjects<\/p>\n<p style=\"text-align: justify;\"><strong>Key benefits of the report:<\/strong><br \/>1. Dry eye disease market report covers a descriptive overview and comprehensive insight of the Dry eye disease epidemiology and Dry eye disease market in the 7 MM (United States, EU5 (Germany, Spain, France, Italy, UK) &amp; Japan.)<br \/>2. Dry eye disease market report provides insights on the current and emerging therapies.<br \/>3. Dry eye disease market report provides a global historical and forecasted market covering drug outreach in 7 MM.<br \/>4. Dry eye disease market report offers an edge that will help in developing business strategies by understanding trends shaping and driving the Dry eye disease market.<\/p>\n<p style=\"text-align: justify;\">&nbsp;<img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/uploads\/14aef5979bf21113d7ccc0dc07f364e2.jpg\" alt=\"\" \/><\/p>\n<p style=\"text-align: justify;\"><strong>&#8220;Individuals over 40 years of age are at a higher risk than those younger than 40.&#8221;<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Request for sample pages:&nbsp;https:\/\/www.delveinsight.com\/sample-request\/dry-eye-disease-market<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>The key players in Dry Eye Disease market are:<\/strong><br \/>1. Oyster Point Pharma<br \/>2. Kala Pharmaceuticals<br \/>3. Ocugen<br \/>4. Topivert<\/p>\n<p style=\"text-align: justify;\"><strong>Drugs covered:<\/strong><br \/>1. OC-01 &amp; OC-02<br \/>2. KPI-121<br \/>3. OCU310<br \/>4. TOP1630<\/p>\n<p style=\"text-align: justify;\"><strong>Table of contents:<\/strong><\/p>\n<p style=\"text-align: justify;\">1. Report Introduction<br \/>2. Dry eye disease Market Overview at a Glance<br \/>3. Dry eye disease Background and Overview<br \/>4. Dry eye disease Epidemiology and Patient Population<br \/>5. Dry eye disease Country- Wise Epidemiology<br \/>5.1. United States<br \/>5.2. EU-5<br \/>5.2.2. Germany<br \/>5.2.3. France<br \/>5.2.4. Italy<br \/>5.2.5. Spain<br \/>5.2.6. United Kingdom<br \/>5.3. Japan<br \/>6. Dry eye disease Treatments &amp; Medical Practices<br \/>7. Dry eye disease Marketed Products<br \/>7.1. Xiidra: Shire<br \/>8. Dry eye disease Emerging Therapies<br \/>8.1. Key Cross Competition<br \/>8.2. OC-01: Oyster Point Pharma<br \/>8.3. OC-02: Oyster Point Pharma<br \/>8.4. OCU310: Ocugen<br \/>8.5. TOP1630: Topivert<br \/>9. Dry eye disease Market Size<br \/>10. 7MM: Country-Wise Market Analysis<br \/>10.1. United States Market Size<br \/>10.2. Germany Market Size<br \/>10.3. France Market Size<br \/>10.4. Italy Market Size<br \/>10.5. Spain Market Size<br \/>10.6. United Kingdom Market Size<br \/>10.7. Japan Market Size<br \/>10.8. Dry eye disease Total Market Size<br \/>11. Dry eye disease Report Methodology<br \/>12. DelveInsight Capabilities<br \/>13. Disclaimer<br \/>14. About DelveInsight<\/p>\n<p style=\"text-align: justify;\"><strong>Related reports:<\/strong><\/p>\n<p style=\"text-align: justify;\"><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/dry-eye-disease-epidemiology-forecast\" target=\"_blank\">Dry eye disease &#8211; Epidemiology Forecast to 2030<\/a><\/p>\n<p style=\"text-align: justify;\"><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/dry-eye-disease-pipeline-insight\" target=\"_blank\">Dry eye disease Pipeline Insight, 2020<\/a><\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/delveinsight.com_55879.html\" rel=\"nofollow\">DelveInsight Business Research LLP<\/a><br \/><strong>Contact Person:<\/strong> Kritika Rehani<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=dry-eye-disease-ded-market-insights-epidemiology-and-market-forecast2028\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> 9193216187<br \/><strong>Address:<\/strong>304 S. Jones Blvd #2432  <br \/><strong>City:<\/strong> Las Vegas<br \/><strong>State:<\/strong> Nevada<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"https:\/\/www.delveinsight.com\/\" target=\"_blank\" rel=\"nofollow\">https:\/\/www.delveinsight.com\/<\/a><\/p>\n<p><object type=\"text\/html\" data=\"https:\/\/www.delveinsight.com\/\" style=\"width:900px; height:400px;\"><\/object><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=dry-eye-disease-ded-market-insights-epidemiology-and-market-forecast2028\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>DelveInsight&#8217;s &#8220;Dry Eye Disease (DED) Market Insights, Epidemiology and Market Forecast-2028&#8221; report delivers an in-depth understanding of the disease, historical and forecasted epidemiology as well as the market trends of DED in EU5 (Germany, Spain, Italy, France and United Kingdom). &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/dry-eye-disease-ded-market-insights-epidemiology-and-market-forecast2028_474742.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401,435,405,406,404],"tags":[],"class_list":["post-474742","post","type-post","status-publish","format-standard","hentry","category-Business","category-Europe","category-Health-Medicine","category-Pharmaceuticals-Biotech","category-US"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/474742","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=474742"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/474742\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=474742"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=474742"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=474742"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}